Cesamet Articles
Clinigen acquires distribution rights to nabilone
9 March 2009
Valeant's 2nd-qtr 2007 income stays constant
13 August 2007
Valeant files IND for Cesamet with FDA
5 March 2007
Cambridge Labs divests nabilone to Valeant
26 February 2007
Par stops Cesamet promotion with Valeant
6 November 2006
Valeant launches new chemotherapy management guide
28 August 2006
Valeant 1st-qtr 2006 loss deepens to $6.4M
15 May 2006
Non-approvable letter for Valeant's Cesamet labeling
9 January 2006
Showing 1-10 of 10 articles
- 1
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
